Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.
Also called NCT02798471
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 290 participants
- Sponsor
- Registry
-
NCT02798471 -
2016-000991-49 -
CTRI/2018/01/011249
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Israel, Kenya, Lebanon, Malaysia, Netherlands, Norway, Panama, Portugal, Romania, Russia, Serbia, Singapore, Slovenia, South Korea, Spain, Taiwan, Thailand, Türkiye, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT02798471. Randomized; single masking; primary purpose treatment. Start 2017-03-27 (actual); primary completion 2022-05-24 (actual). Results posted on 2023-03-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
- Condition
- Venous Thromboembolism (VTE)
- Condition
- Pulmonary Embolism
- Condition
- Deep Vein Thrombosis (DVT (deep vein thrombosis))
- Intervention (Drug)
- Edoxaban
- Intervention (Drug)
- Standard of Care
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02798471- Content hash
201789c342ea56c66d370ed58943c9a7e3a49c5cf5e19fa4743cb2c9be0d0b22